M Hu, W Li, Y Zhang, C Liang, J Tan, Y Wang - Biomedicine & …, 2023 - Elsevier
Venetoclax is a potent inhibitor that specifically targets B-cell lymphoma-2 (BCL-2), which
has been demonstrated to be effective in preclinical studies utilizing acute myeloid leukemia …